SkinBioTherapeutics plc (AIM:SBTX)

London · Delayed Price · Currency is GBP · Price in GBX

11.50

-0.75 (-6.12%)

Jul 24, 2026, 3:51 PM GMT

SkinBioTherapeutics Financials Overview

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	4.46	3.87	1.21	0.13	0.07	-
Revenue Growth	15.23%	220.12%	815.26%	76.64%	-	-
Gross Profit	2.42	2.09	0.68	0.09	0.05	-
Operating Income	-2.1	-2.13	-2.91	-3	-2.98	-1.5
Net Income	-1.5	-1.74	-2.88	-2.84	-2.79	-1.43
Earnings Per Share	-0.00	-0.00	-0.02	-0.02	-0.02	-0.01
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
United Kingdom	3.75	3.12	0.99	0.12	0.06
Europe	1.23	1.22	0.1	0	-
United States of America	0.1	0.15	0.04	0.01	0.02
Rest of The World	0.15	0.14	0.08	-	-
Total	5.23	4.64	1.21	0.13	0.07

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	3.12	4.78	0.8	1.31	1.8	4.61
Total Debt	0.94	0.99	0.82	0.1	0.13	0.14
Net Cash (Debt)	2.19	3.79	-0.02	1.21	1.68	4.47
Net Cash Growth	-42.27%	-	-	-27.78%	-62.48%	107.04%
Net Cash Per Share	0.01	0.02	-0.00	0.01	0.01	0.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	-1.94	-1.24	-2.73	-2.65	-2.67	-1.56
Capital Expenditures	-0.03	-0.01	-0.01	-0.09	-	-
Free Cash Flow	-1.97	-1.24	-2.74	-2.73	-2.67	-1.56
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	54.22%	54.02%	56.51%	64.51%	60.64%	-
Operating Margin	-47.06%	-54.94%	-240.36%	-2271.26%	-3988.83%	-
Pretax Margin	-32.99%	-44.40%	-243.98%	-2277.98%	-4002.38%	-
Profit Margin	-33.72%	-45.05%	-237.95%	-2146.91%	-3735.37%	-
FCF Margin	-44.18%	-32.08%	-226.80%	-2071.02%	-3575.44%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PS Ratio	5.83	9.89	13.49	155.91	424.66	-